BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 19692259)

  • 21. Surgical resection for multifocal (T4) non-small cell lung cancer: is the T4 designation valid?
    Port JL; Korst RJ; Lee PC; Kansler AL; Kerem Y; Altorki NK
    Ann Thorac Surg; 2007 Feb; 83(2):397-400. PubMed ID: 17257959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung.
    Riquet M; Manac'h D; Le Pimpec-Barthes F; Dujon A; Chehab A
    Ann Thorac Surg; 1999 Jun; 67(6):1572-6. PubMed ID: 10391257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic impact of main bronchial lymph node involvement in non-small cell lung carcinoma: suggestions for a modification of the staging system.
    Shimada Y; Tsuboi M; Saji H; Miyajima K; Usuda J; Uchida O; Kajiwara N; Ohira T; Hirano T; Kato H; Ikeda N
    Ann Thorac Surg; 2009 Nov; 88(5):1583-8. PubMed ID: 19853116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.
    Lee JG; Lee CY; Park IK; Kim DJ; Park SY; Kim KD; Chung KY
    Ann Thorac Surg; 2008 Jan; 85(1):211-5. PubMed ID: 18154813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer.
    Asamura H; Chansky K; Crowley J; Goldstraw P; Rusch VW; Vansteenkiste JF; Watanabe H; Wu YL; Zielinski M; Ball D; Rami-Porta R;
    J Thorac Oncol; 2015 Dec; 10(12):1675-84. PubMed ID: 26709477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical impact of the use of the revised International Association for the Study of Lung Cancer staging system to operable non-small-cell lung cancers.
    Lyons G; Quadrelli S; Jordan P; Colt H; Chimondeguy D
    Lung Cancer; 2011 Nov; 74(2):244-7. PubMed ID: 21411177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applicability of the revised International Association for the Study of Lung Cancer staging system to operable non-small-cell lung cancers.
    Suzuki M; Yoshida S; Tamura H; Wada H; Moriya Y; Hoshino H; Shibuya K; Yoshino I
    Eur J Cardiothorac Surg; 2009 Dec; 36(6):1031-6. PubMed ID: 19692261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer.
    Takeda S; Fukai S; Komatsu H; Nemoto E; Nakamura K; Murakami M;
    Ann Thorac Surg; 2005 Apr; 79(4):1142-6. PubMed ID: 15797041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
    Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
    Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Verification of the newly proposed T category (seventh edition of the tumor, node, and metastasis classification) from a clinicopathological viewpoint in non-small cell lung cancer-special reference to tumor size.
    Yano T; Morodomi Y; Ito K; Yoshida T; Haro A; Shoji F; Koga T; Maehara Y
    J Thorac Oncol; 2010 Jan; 5(1):45-8. PubMed ID: 19884855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Size of Stage IIIA primary lung cancers and survival: a surveillance, epidemiology and end results database analysis.
    Maximus S; Nguyen DV; Mu Y; Calhoun RF; Cooke DT
    Am Surg; 2012 Nov; 78(11):1232-7. PubMed ID: 23089441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis.
    Marra A; Hillejan L; Zaboura G; Fujimoto T; Greschuchna D; Stamatis G
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):543-53. PubMed ID: 12658196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Re-appraisal of N2 disease by lymphatic drainage pattern for non-small-cell lung cancers: by terms of nodal stations, zones, chains, and a composite.
    Zheng H; Wang LM; Bao F; Jiang GN; Xie HK; Ding JA; Hu XF; Chen C
    Lung Cancer; 2011 Dec; 74(3):497-503. PubMed ID: 21529990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
    Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
    Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
    Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A
    Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prognostic significance of intrapulmonary metastases in cases of surgically treated lung cancer].
    Szöke T; Troján I; Furák J; Tiszlavicz L; Balogh A
    Magy Onkol; 2003; 47(4):397-401. PubMed ID: 14716437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
    Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station.
    Ichinose Y; Kato H; Koike T; Tsuchiya R; Fujisawa T; Shimizu N; Watanabe Y; Mitsudomi T; Yoshimura M; Tsuboi M;
    J Thorac Cardiovasc Surg; 2001 Oct; 122(4):803-8. PubMed ID: 11581617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-small cell lung cancer with ipsilateral pulmonary metastases: prognosis analysis and staging assessment.
    Lee JG; Lee CY; Kim DJ; Chung KY; Park IK
    Eur J Cardiothorac Surg; 2008 Mar; 33(3):480-4. PubMed ID: 18249000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.